Geron Corp (GERN)

$1.25 -0.02 (-1.57%)
Market Cap 810.28M
Revenue (ttm) 76.99M
Net Income (ttm) -174.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -226.74%
Debt to Equity Ratio 0.46
Volume 10,707,801
Avg Vol 8,919,112
Day's Range N/A - N/A
Shares Out 638.02M
Stochastic %K 11%
Beta 0.63
Analysts Sell
Price Target $3.56

Company Profile

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 650 473 7700
Address:
919 East Hillsdale Boulevard, Suite 250, Foster City, United States
ZdP2
ZdP2 Sep. 16 at 7:52 PM
$GERN Closing the gap to 1.2 imo. I might enter when it does.
0 · Reply
highnihilism
highnihilism Sep. 16 at 6:59 PM
IWM: Russell 2000 → $EGHT 8X8 $LZ Legalzoom $AVDX Avidxchange $CNK Cinemark Holdings Cinemark $GERN Geron
0 · Reply
jb06000
jb06000 Sep. 16 at 4:42 PM
$GERN still holding will go up be patient
0 · Reply
Find_the_Cure
Find_the_Cure Sep. 16 at 4:28 PM
$GERN sad
0 · Reply
highnihilism
highnihilism Sep. 16 at 3:06 PM
Biotech → $DNLI Denali Therapeutics $AKRO Akero Therapeutics $KROS Keros Therapeutics $SYRE Spyre Therapeutics $GERN Geron
0 · Reply
SVTcobra
SVTcobra Sep. 16 at 2:20 PM
$GERN after holding this pig since 2017 I could not take it anymore. Dumped all I had left today and rolled it into $NLR. Good luck to you all in $GERN. Maybe it does something someday but I should have 6x’d this dead money by now and instead it’s a loss.
1 · Reply
ZoeyTanner
ZoeyTanner Sep. 16 at 1:49 PM
$GERN No interest, no pulse, perhaps check Fierce Pharma for reasons for no partners ex-us with mico geron. UK and europe, in general is death spiral for biotech. Governments putting the clamps on. However, not the reason we are 1.27 pennies. Follow the money
1 · Reply
Polip
Polip Sep. 16 at 12:51 PM
$GERN 15 days to cover! High squeeze potential $XBI
0 · Reply
GISBlaster98
GISBlaster98 Sep. 15 at 10:49 PM
$GERN Listen to the CEO speak using the link I provided and you will get the answer to your question
0 · Reply
GoldenKnightsFan
GoldenKnightsFan Sep. 15 at 10:31 PM
$GERN Any near term catalyst on this one? Thanks for your answers in advance.
0 · Reply
Latest News on GERN
Geron to Participate in the 2025 Wells Fargo Healthcare Conference

Aug 27, 2025, 4:05 PM EDT - 20 days ago

Geron to Participate in the 2025 Wells Fargo Healthcare Conference

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 18, 2025, 4:01 PM EDT - 4 weeks ago

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Investors: Company Investigated by the Portnoy Law Firm

Aug 14, 2025, 5:23 PM EDT - 4 weeks ago

Geron Corporation Investors: Company Investigated by the Portnoy Law Firm

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Aug 8, 2025, 4:01 PM EDT - 5 weeks ago

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Geron: I Think We've Seen This Movie Before

Aug 8, 2025, 9:30 AM EDT - 5 weeks ago

Geron: I Think We've Seen This Movie Before

Geron Corporation (GERN) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 3:01 PM EDT - 5 weeks ago

Geron Corporation (GERN) Q2 2025 Earnings Call Transcript

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Aug 6, 2025, 7:01 AM EDT - 5 weeks ago

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Geron Appoints Harout Semerjian as President and Chief Executive Officer

Aug 6, 2025, 7:00 AM EDT - 5 weeks ago

Geron Appoints Harout Semerjian as President and Chief Executive Officer

Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025

Jul 28, 2025, 8:00 AM EDT - 7 weeks ago

Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025

Conservative Vision Of A Positive Future For Geron

Jun 3, 2025, 9:57 AM EDT - 3 months ago

Conservative Vision Of A Positive Future For Geron

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

May 28, 2025, 8:30 AM EDT - 3 months ago

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

Geron: Rytelo's Limited Adoption And Flat Demand Signal Troubled Outlook (Rating Downgrade)

May 9, 2025, 8:28 AM EDT - 4 months ago

Geron: Rytelo's Limited Adoption And Flat Demand Signal Troubled Outlook (Rating Downgrade)

GERN Investors Have Opportunity to Join Geron Corporation Fraud Investigation with the Schall Law Firm

May 8, 2025, 11:24 PM EDT - 4 months ago

GERN Investors Have Opportunity to Join Geron Corporation Fraud Investigation with the Schall Law Firm

Geron Corporation (GERN) Q1 2025 Earnings Call Transcript

May 7, 2025, 12:50 PM EDT - 4 months ago

Geron Corporation (GERN) Q1 2025 Earnings Call Transcript

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 12, 2025 in Geron Lawsuit – GERN

May 7, 2025, 12:33 PM EDT - 4 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 12, 2025 in Geron Lawsuit – GERN

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 7, 2025, 7:00 AM EDT - 4 months ago

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

Apr 24, 2025, 9:33 PM EDT - 5 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 18, 2025, 4:30 PM EDT - 5 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

Apr 9, 2025, 10:40 AM EDT - 5 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments

Mar 31, 2025, 4:32 PM EDT - 6 months ago

Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments

Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025

Mar 31, 2025, 4:30 PM EDT - 6 months ago

Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025

Biotech Stocks Q1 2025 Recap: Winners And Underperformers

Mar 31, 2025, 2:34 PM EDT - 6 months ago

Biotech Stocks Q1 2025 Recap: Winners And Underperformers

CMRX CRVO CVS LLY NVO SEPN

Lifshitz Law PLLC Announces Investigations of Geron Corporation (NASDAQ: GERN), and The Bancorp, Inc. (NASDAQ: TBBK)

Mar 22, 2025, 12:31 PM EDT - 6 months ago

Lifshitz Law PLLC Announces Investigations of Geron Corporation (NASDAQ: GERN), and The Bancorp, Inc. (NASDAQ: TBBK)

TBBK

Geron Corp: How Concerned Should We Be About Rytelo Sales?

Mar 17, 2025, 5:19 PM EDT - 6 months ago

Geron Corp: How Concerned Should We Be About Rytelo Sales?

GERN Investors Have Opportunity to Lead the Geron Corporation Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - GERN

Mar 17, 2025, 7:42 AM EDT - 6 months ago

GERN Investors Have Opportunity to Lead the Geron Corporation Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - GERN

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)

Mar 14, 2025, 3:04 PM EDT - 6 months ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)

ZdP2
ZdP2 Sep. 16 at 7:52 PM
$GERN Closing the gap to 1.2 imo. I might enter when it does.
0 · Reply
highnihilism
highnihilism Sep. 16 at 6:59 PM
IWM: Russell 2000 → $EGHT 8X8 $LZ Legalzoom $AVDX Avidxchange $CNK Cinemark Holdings Cinemark $GERN Geron
0 · Reply
jb06000
jb06000 Sep. 16 at 4:42 PM
$GERN still holding will go up be patient
0 · Reply
Find_the_Cure
Find_the_Cure Sep. 16 at 4:28 PM
$GERN sad
0 · Reply
highnihilism
highnihilism Sep. 16 at 3:06 PM
Biotech → $DNLI Denali Therapeutics $AKRO Akero Therapeutics $KROS Keros Therapeutics $SYRE Spyre Therapeutics $GERN Geron
0 · Reply
SVTcobra
SVTcobra Sep. 16 at 2:20 PM
$GERN after holding this pig since 2017 I could not take it anymore. Dumped all I had left today and rolled it into $NLR. Good luck to you all in $GERN. Maybe it does something someday but I should have 6x’d this dead money by now and instead it’s a loss.
1 · Reply
ZoeyTanner
ZoeyTanner Sep. 16 at 1:49 PM
$GERN No interest, no pulse, perhaps check Fierce Pharma for reasons for no partners ex-us with mico geron. UK and europe, in general is death spiral for biotech. Governments putting the clamps on. However, not the reason we are 1.27 pennies. Follow the money
1 · Reply
Polip
Polip Sep. 16 at 12:51 PM
$GERN 15 days to cover! High squeeze potential $XBI
0 · Reply
GISBlaster98
GISBlaster98 Sep. 15 at 10:49 PM
$GERN Listen to the CEO speak using the link I provided and you will get the answer to your question
0 · Reply
GoldenKnightsFan
GoldenKnightsFan Sep. 15 at 10:31 PM
$GERN Any near term catalyst on this one? Thanks for your answers in advance.
0 · Reply
GISBlaster98
GISBlaster98 Sep. 15 at 7:14 PM
$GERN https://event.webcasts.com/starthere.jsp?ei=1731382&tp_key=715e0eaa49
0 · Reply
GISBlaster98
GISBlaster98 Sep. 15 at 4:53 PM
$GERN CEO has been in his job for 5 weeks…. LMAO
0 · Reply
ZoeyTanner
ZoeyTanner Sep. 15 at 3:57 PM
$GERN Endless pain for those who hold. CEO resting on laurels, I am afraid.
1 · Reply
GISBlaster98
GISBlaster98 Sep. 15 at 1:19 PM
$GERN Do yourself a favor and listen to the Wells Fargo Healthcare meeting with the new CEO. He answers your question and I think he was very impressive and realistic as to the future of GERN
1 · Reply
JRobb66
JRobb66 Sep. 15 at 7:44 AM
$GERN what happened to Europe? It’s been close to 3 months since approval Shouldn’t a partner and all kinks had been worked out prior to approval?
3 · Reply
GISBlaster98
GISBlaster98 Sep. 14 at 2:12 PM
$GERN I have both stocks. A real good first interview with the new GERN CIO ( in my opinion ) last week. Also excited about MAIA for solid tumors.
0 · Reply
telomerase
telomerase Sep. 14 at 2:01 PM
$GERN I pipetted the first GRN163L (now Rytelo) onto HeLa cells back in 2003. But it's 2025 now, and the second-generation anti-telomere drugs are here. Look at MAIA's Phase 2 results in NSCLC.
0 · Reply
DAWGNuts
DAWGNuts Sep. 13 at 2:32 PM
$GERN seems pretty far fetched. But one can dream.
2 · Reply
AxelWiz
AxelWiz Sep. 12 at 8:51 PM
$GERN pos stock :(
1 · Reply
ZoeyTanner
ZoeyTanner Sep. 12 at 10:40 AM
$GERN The science here is impeccable, however, everything else sucks badly. One look at 6 months chart, enough said.
2 · Reply
Rickster4retirement
Rickster4retirement Sep. 12 at 12:48 AM
$GERN Leadership could learn something from $GALT.
2 · Reply
eunkyo
eunkyo Sep. 11 at 8:22 PM
$GERN Settlement Date 08/29/2025 Short Interest 88,536,749 Avg.Daily Share Volume 5,811,216 Days to Cover 15.235494 https://www.nasdaq.com/market-activity/stocks/gern/short-interest
0 · Reply